관절경 검사 시장 : 제품 유형, 시술 유형, 용도, 최종 사용자별 - 세계 시장 예측(2026-2032년)

The Arthroscopy Market is projected to grow by USD 9.45 billion at a CAGR of 5.14% by 2032.

Arthroscopy Market Introduction

The arthroscopy market sits at the center of minimally invasive orthopedic surgery, spanning arthroscopes, visualization systems, powered shavers, radiofrequency ablation devices, fluid management platforms, suture anchors, implants, cannulas, and procedure-specific instruments for knee, shoulder, hip, ankle, wrist, and elbow interventions.

Demand is supported by measurable disease burden and care-model change. The World Health Organization reports that approximately 1.71 billion people live with musculoskeletal conditions globally, while osteoarthritis affected about 528 million people in 2019. As health systems prioritize shorter length of stay, faster rehabilitation, and outpatient orthopedic pathways, arthroscopy devices are increasingly evaluated on clinical precision, workflow efficiency, total cost of care, infection control, and compatibility with digital operating rooms.

Transformative Shifts in Arthroscopy

The arthroscopy landscape is shifting from product-led purchasing toward value-led procedural ecosystems. Hospitals and ambulatory surgery centers are looking beyond stand-alone scopes and instruments to integrated platforms that combine high-definition and 4K imaging, disposable and reusable device strategies, fluid control, tissue management, repair implants, and analytics-enabled service models.

Another major shift is the movement of suitable orthopedic procedures into outpatient and ambulatory settings, particularly in North America and parts of Europe. This creates demand for compact towers, faster room turnover, reliable sterilization pathways, and procedure packs that reduce variability. At the same time, surgeon preference remains important, making clinical education, cadaveric training, simulation, and evidence-backed device differentiation essential for arthroscopy manufacturers.

Cumulative Impact of AI in Arthroscopy

Artificial intelligence is beginning to reshape arthroscopy through image enhancement, surgical video analytics, instrument tracking, automated documentation, workflow optimization, and training support. While AI adoption in arthroscopy is still earlier than in radiology, peer-reviewed orthopedic research increasingly explores machine learning for lesion detection, cartilage assessment, kinematic analysis, phase recognition, and surgical skills evaluation.

For industry leaders, the cumulative impact of AI is strategic rather than incremental. AI-enabled arthroscopy platforms can support consistency, reduce documentation burden, create searchable surgical video libraries, and improve post-market evidence generation. However, adoption depends on validated algorithms, cybersecurity, interoperability with hospital systems, regulatory compliance, explainable outputs, and clear demonstration that AI improves clinical workflow without replacing surgeon judgment.

Key Regional Insights for Arthroscopy

North America remains a leading arthroscopy market because of high procedure volumes, mature sports medicine programs, advanced ambulatory surgery infrastructure, and established reimbursement pathways for selected orthopedic interventions. Europe benefits from specialized orthopedic centers, aging populations, and broad use of minimally invasive techniques, although procurement is often shaped by tender systems, clinical evidence requirements, and health technology assessment standards.

Asia-Pacific is expanding as China, India, Japan, South Korea, and Australia invest in orthopedic capacity, surgeon training, medical technology access, and private hospital networks. Latin America shows opportunity through Brazil and Mexico, where sports medicine and private healthcare demand support arthroscopy adoption. The Middle East is supported by specialty hospitals, medical tourism, and government healthcare modernization, while Africa remains a developing opportunity where adoption depends on operating room infrastructure, affordability, orthopedic training, sterilization capacity, and access to reliable surgical equipment.

Key Group Insights for Arthroscopy

Across ASEAN, arthroscopy demand is supported by expanding private hospitals, medical tourism hubs, and rising orthopedic specialization in countries such as Singapore, Thailand, Malaysia, Indonesia, and Vietnam. The GCC is prioritizing advanced specialty care, premium hospital infrastructure, and sports medicine capabilities, creating openings for high-quality arthroscopy towers, implants, repair systems, and surgeon education programs.

The European Union emphasizes safety, clinical evidence, sustainability, traceability, and procurement discipline under rigorous medical device regulation, while BRICS countries combine large patient pools with diverse affordability, reimbursement, and access challenges. G7 markets generally lead in innovation adoption, clinical research, outpatient orthopedic pathways, and premium device utilization. NATO-aligned markets include many high-income health systems where supply resilience, cybersecurity, data governance, and trusted vendor relationships increasingly influence arthroscopy procurement decisions.

Key Country Insights for Arthroscopy

The United States is the most influential arthroscopy market, supported by sports medicine, ambulatory surgery centers, clinical innovation, and strong surgeon specialization. Canada shows steady demand within a publicly funded system focused on access and wait-time management, while Mexico benefits from private hospitals, cross-border care, and expanding orthopedic services. Brazil leads Latin American demand with a large healthcare base, active sports medicine community, and growing use of minimally invasive orthopedic procedures.

In Europe, the United Kingdom, Germany, France, Italy, and Spain are mature arthroscopy markets shaped by aging demographics, public procurement, hospital budget discipline, and clinical evidence requirements, while Russia presents demand linked to orthopedic modernization, local supply considerations, and import dynamics. China and India offer scale, rising procedure capacity, expanding domestic manufacturing, and growing surgeon training networks. Japan, Australia, and South Korea stand out for advanced clinical practice, high technology adoption, sports injury management, and strong surgeon engagement in minimally invasive orthopedic procedures.

Actionable Recommendations for Industry Leaders

Industry leaders should align arthroscopy portfolios with the shift toward outpatient, value-based orthopedic care. Priority actions include designing cost-efficient procedure ecosystems, improving instrument durability, strengthening sterilization compatibility, offering flexible capital models, and supporting disposable-reusable balance based on infection control, sustainability, and economics.

Manufacturers should invest in surgeon training, clinical evidence, AI-ready imaging architecture, service uptime, cybersecurity, and digital integration with hospital systems. Commercial teams should localize strategies by region, with premium innovation emphasized in mature markets and affordability, training, reimbursement navigation, and distribution strength prioritized in emerging markets.

Research Methodology

This executive summary is built from a secondary research framework that synthesizes public health data, regulatory perspectives, orthopedic care trends, medical technology adoption patterns, and region-specific healthcare infrastructure indicators. Key reference points include widely cited sources such as the World Health Organization for musculoskeletal disease burden and recognized healthcare policy bodies for outpatient surgery, medical device regulation, and health-system modernization trends.

The analysis applies market triangulation principles by combining demand-side indicators, supply-side innovation signals, clinical adoption patterns, competitive positioning themes, and macroeconomic healthcare factors. Insights are structured to support SEO relevance for arthroscopy devices, minimally invasive orthopedic surgery, sports medicine, ambulatory surgery centers, arthroscopic implants, visualization systems, fluid management, tissue repair, and AI in orthopedic surgery.

Conclusion

Arthroscopy is evolving from a minimally invasive procedure category into a connected orthopedic care platform. Growth drivers include musculoskeletal disease burden, sports injury management, aging populations, outpatient surgery expansion, and continuous innovation in visualization, implants, tissue management, repair systems, and digital workflow.

The next phase of competitive advantage will come from evidence-backed outcomes, AI-enabled workflow intelligence, regional execution, and integrated solutions that help surgeons deliver precise, efficient, and reproducible care. Organizations that combine clinical credibility with scalable technology, resilient supply chains, and localized access strategies will be well positioned in the global arthroscopy market.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Arthroscopy Market, by Product Type

• 7.1. Arthroscopes
• 7.2. Visualization Systems
  • 7.2.1. Camera Systems
  • 7.2.2. Light Source Systems
  • 7.2.3. Video Processors
• 7.3. Fluid Management Systems
  • 7.3.1. Fluid Pumps
  • 7.3.2. Fluid Control Systems
  • 7.3.3. Tubing Sets
• 7.4. Radiofrequency Systems
• 7.5. Arthroscopic Implants
  • 7.5.1. Suture Anchors
  • 7.5.2. Interference Screws
  • 7.5.3. Pins
• 7.6. Accessories & Consumables
  • 7.6.1. Cannulas
  • 7.6.2. Probes
  • 7.6.3. Forceps
  • 7.6.4. Graspers

8. Arthroscopy Market, by Procedure Type

• 8.1. Diagnostic Arthroscopy
• 8.2. Operative Arthroscopy

9. Arthroscopy Market, by Application

• 9.1. Foot & Ankle Arthroscopy
  • 9.1.1. Ligament Repair
  • 9.1.2. Cartilage Treatment
• 9.2. Elbow Arthroscopy
• 9.3. Hip Arthroscopy
• 9.4. Knee Arthroscopy
  • 9.4.1. ACL Reconstruction
  • 9.4.2. Meniscus Repair
  • 9.4.3. Cartilage Repair
• 9.5. Shoulder Arthroscopy
  • 9.5.1. Rotator Cuff Repair
  • 9.5.2. Labral Repair
• 9.6. Wrist Arthroscopy
• 9.7. Spine Arthroscopy

10. Arthroscopy Market, by End User

• 10.1. Ambulatory Surgery Centers
• 10.2. Hospitals
  • 10.2.1. Public Hospitals
  • 10.2.2. Private Hospitals
• 10.3. Orthopedic Clinics
• 10.4. Academic & Research Institutes

11. Arthroscopy Market, by Region

• 11.1. Asia-Pacific
• 11.2. North America
• 11.3. Latin America
• 11.4. Europe
• 11.5. Middle East
• 11.6. Africa

12. Arthroscopy Market, by Group

• 12.1. ASEAN
• 12.2. GCC
• 12.3. European Union
• 12.4. BRICS
• 12.5. G7
• 12.6. NATO

13. Arthroscopy Market, by Country

• 13.1. United States
• 13.2. Canada
• 13.3. Mexico
• 13.4. Brazil
• 13.5. United Kingdom
• 13.6. Germany
• 13.7. France
• 13.8. Russia
• 13.9. Italy
• 13.10. Spain
• 13.11. China
• 13.12. India
• 13.13. Japan
• 13.14. Australia
• 13.15. South Korea

14. Competitive Landscape

• 14.1. Market Concentration Analysis, 2025
  • 14.1.1. Concentration Ratio (CR)
  • 14.1.2. Herfindahl Hirschman Index (HHI)
• 14.2. Recent Developments & Impact Analysis, 2025
• 14.3. Product Portfolio Analysis, 2025
• 14.4. Benchmarking Analysis, 2025

15. Company Profiles

• 15.1. Arthrex, Inc.
• 15.2. B. Braun Melsungen AG
• 15.3. Biovision Veterinary Endoscopy, LLC
• 15.4. CONMED Corporation
• 15.5. EndoMed Systems GmbH
• 15.6. Fujifilm Holdings Corporation
• 15.7. GPC Medical Ltd.
• 15.8. Johnson & Johnson
• 15.9. Joimax GmbH
• 15.10. Karl Storz SE & Co. KG
• 15.11. Linvatec Corporation
• 15.12. Medtronic plc
• 15.13. MicroPort Scientific Corporation
• 15.14. Olympus Corporation
• 15.15. Richard Wolf GmbH
• 15.16. Rudolf Medical GmbH + Co. KG
• 15.17. Smith & Nephew plc
• 15.18. Stryker Corporation
• 15.19. Tonglu Wanhe Medical Instrument Co., Ltd.
• 15.20. Wright Medical Group N.V.
• 15.21. XION GmbH
• 15.22. Zimmer Biomet Holdings, Inc.